Kostiainen, I.; Simonen, P.; Aaltonen, K.; Lindén, R.; Karppinen, N.; Gordin, D.; Rapola, J.; Schalin-Jäntti, C.; Matikainen, N.
The Value of Repeat 5-HIAA Measurements as a Predictor of Carcinoid Heart Disease: A Prospective 5-Year Follow-Up Study in Patients with Small Intestinal Neuroendocrine Tumors. Cancers 2024, 16, 3896.
https://doi.org/10.3390/cancers16233896
AMA Style
Kostiainen I, Simonen P, Aaltonen K, Lindén R, Karppinen N, Gordin D, Rapola J, Schalin-Jäntti C, Matikainen N.
The Value of Repeat 5-HIAA Measurements as a Predictor of Carcinoid Heart Disease: A Prospective 5-Year Follow-Up Study in Patients with Small Intestinal Neuroendocrine Tumors. Cancers. 2024; 16(23):3896.
https://doi.org/10.3390/cancers16233896
Chicago/Turabian Style
Kostiainen, Iiro, Piia Simonen, Katri Aaltonen, Riikka Lindén, Noora Karppinen, Daniel Gordin, Janne Rapola, Camilla Schalin-Jäntti, and Niina Matikainen.
2024. "The Value of Repeat 5-HIAA Measurements as a Predictor of Carcinoid Heart Disease: A Prospective 5-Year Follow-Up Study in Patients with Small Intestinal Neuroendocrine Tumors" Cancers 16, no. 23: 3896.
https://doi.org/10.3390/cancers16233896
APA Style
Kostiainen, I., Simonen, P., Aaltonen, K., Lindén, R., Karppinen, N., Gordin, D., Rapola, J., Schalin-Jäntti, C., & Matikainen, N.
(2024). The Value of Repeat 5-HIAA Measurements as a Predictor of Carcinoid Heart Disease: A Prospective 5-Year Follow-Up Study in Patients with Small Intestinal Neuroendocrine Tumors. Cancers, 16(23), 3896.
https://doi.org/10.3390/cancers16233896
